Gene Query: CSF1R

Dataset Description Geneva Score
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 136.38
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 121.49
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 84.38
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 71.4
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 71.4
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 59.58
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 59.58
Pharmacologic inhibition of STAT5 in AML 59.57
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 57.95
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 55.26
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 50.16
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 49.8
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 49.8
Transcription control by the ENL YEATS domain in acute leukemia 49.38
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 49.38
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 46.13
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 44.9
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 44.68
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 42.24
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 40.92
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 39.53
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 38.91
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 37.68
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 36.95
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 36.31
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 36.26
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 35.58
Intron retention induced by microsatellite expansions as a disease biomarker. 33.63
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 32.74
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 31.33
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 31.33
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 29.09
CircRNAome diversity in human mature B-cells, T-cells and monocytes 28.31
Comparing gene expression in iPSC derived RPE from control and AMD donors 28.29
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 27.38
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 27.38
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 26.71
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 26.34
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 25.51
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 25.0
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 25.0
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 24.95
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 24.38
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 24.1
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 24.04
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 21.88
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 21.7
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 21.39
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 21.22
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 21.01
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 21.01
RNA-seq of stable and unstable section of human atherosclerotic plaques 20.83
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 20.7
Nonpregnant and term pregnant human myometrial tissues 20.7
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 20.69
Primary human trophoblast from term placenta 20.61
RNA-sequencing of human tendon after injury 19.88
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 19.76
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 19.63
ZIKV infection of monocytes activates inflammasome pathways 19.41
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 19.01
Aortic Valve Tissue: Stenosis vs. Sclerosis 18.82
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 18.55
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 18.54
Microglia innatly develop within cerebral organoids 18.18
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 18.03
Widespread regulated alternative splicing of single codons accelerates proteome evolution 18.01
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 17.53
A map of gene expression in neutrophil-like cell lines 17.53
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 17.44
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 16.91
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 16.91
Transcription elongation regulates genome 3D structure 16.82
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 16.58
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 16.37
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 16.32
Efficient derivation of microglia-like cells from human pluripotent stem cells 16.32
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 16.11
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 15.93
The pioneer factor CEBPA modulates vitamin D signaling 15.9
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 15.9
Reprogrammed myeloid cell transcriptomes in NSCLC 15.81
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 15.59
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 15.33
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 15.23
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 15.18
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 15.18
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 15.12
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 14.35
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 14.34
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 14.32
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 14.24
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 14.19
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 14.06
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 14.0
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 13.81
Anti-inflammatory effect of indoleacrylic acid (IA) 13.61
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 13.6
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 13.46
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 13.38
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 13.09
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 13.09
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 13.08
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 12.9
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 12.71
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 12.57
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 12.53
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 12.5
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 12.31
Single cell transcriptome of peritoneal cells 12.18
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 12.15
MAIT cell RNA sequencing 12.01
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 11.86
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 11.65
RNA-seq analysis of the human fetal kidney. 11.47
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 11.42
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 11.4
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 11.36
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 11.12
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 11.06
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 11.0
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 10.94
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 10.87
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 10.73
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 10.55
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 10.5
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 10.5
Role of cervicovaginal microbiota in genital inflammation 10.34
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 10.19
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 10.19
Transcriptomes of human monocytes after ex vivo exposure to uric acid 9.94
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 9.81
Aging-associated patterns in the expression of human endogenous retroviruses 9.41
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 9.29
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 9.28
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 9.28
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 9.19
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 9.03
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 9.01
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 8.97
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 8.97
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 8.77
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 8.64
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 8.61
Targeting MTHFD2 in Acute Myeloid Leukemia 8.61
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 8.47
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 8.47
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 8.46
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 8.43
RNA-Seq of the corpus callosum from 12 individuals 8.42
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 8.41
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 8.28
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 8.25
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 8.25
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 8.12
RNA-seq of CD33 KO and control HSPCs 8.1
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 8.05
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 8.03
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 7.96
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 7.71
MEIS1 regulates hematopoiesis in hPSCs 7.7
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 7.68
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 7.47
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 7.34
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 7.31
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 7.31
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 7.28
The Genomic Landscape of Atypical Fibroxanthoma 7.27
An acquired vulnerability of drug resistant melanoma with therapeutic potential 7.24
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 7.24
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 7.16
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 7.13
Generation and functional characterization of MDSC-like cells 7.12
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 7.11
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 7.11
RNA-seq in endometrial stromal tumors 7.07
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 7.04
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 6.99
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 6.86
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 6.84
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 6.84
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 6.8
Tpl-2 and MEK small molecule inhibitors 6.71
Tpl-2 small molecule project 6.71
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 6.66
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 6.62
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 6.59
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 6.53
JAK dependent survival of ALK- ALCL 6.51
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 6.47
RNA-Seq in neutrophils from Antiphospholipid Syndrome 6.41
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 6.4
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 6.32
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 6.26
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 6.26
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 6.24
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 6.21
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 6.17
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 6.17
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 6.08
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 6.06
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 6.04
Gene expression profiling of papillary thyroid cancer from central and invasive regions 6.01
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 5.96
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 5.91
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 5.87
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 5.85
Short and Long RNA sequencing of human mature erythrocytes 5.77
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 5.71
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 5.7
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 5.69
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 5.67
The Glioma-Infiltrating T Cell Receptor Repertoire 5.66
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 5.65
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 5.63
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 5.63
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 5.62
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 5.6
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 5.58
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 5.57
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 5.54
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 5.51
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 5.5
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 5.47
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 5.39
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 5.36
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 5.34
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 5.32
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 5.22
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 5.2
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 5.19
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 5.1
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 5.04
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 5.0
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 4.95
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 4.93
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 4.9
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 4.88
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 4.88
Identification of renal resident macrophages across species 4.88
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 4.82
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 4.82
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 4.8
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 4.75
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 4.73
Identification of renal resident macrophages across species [C1] 4.73
Transcriptional profile in human S. haematobium infection 4.7
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 4.66
Alteration of the microRNA network during the progression of Alzheimer’s disease 4.6
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 4.56
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 4.54
Universal alternative splicing of noncoding exons 4.49
Transcriptomic analysis of frontal fibrosing alopecia 4.47
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 4.44
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 4.4
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 4.37
Gene expression profile difference among renal location in a stone former 4.35
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 4.27
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 4.26
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 4.25
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 4.25
LncRNA expression profiling of ischemic stroke patients 4.24
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 4.22
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 4.12
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 4.08
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 4.07
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 4.07
Leucegene: ALL sequencing 4.05
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 3.99
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 3.96
Genome-wide identification of cancer-specific alternative splicing in circRNA 3.96
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 3.89
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 3.88
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 3.84
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 3.84
Expression charcaterization of an internal protocol developed to differentiate RPE cells 3.84
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 3.84
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 3.79
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 3.79
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 3.79
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 3.76
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 3.71
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 3.7
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 3.7
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 3.69
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 3.69
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 3.69
Zika virus infection reprograms global transcription of host cells to allow sustained infection 3.65
The DNA methylation landscape of human melanoma 3.65
The DNA methylation landscape of human melanoma [RNA-Seq] 3.65
CHD1 regulates cell fate determination by activation of differentiation-induced genes 3.61
circNFIB suppresses lymphatic metastasis of pancreatic cancer 3.54
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 3.53
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 3.52
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 3.46
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 3.42
ML29755 RNA-seq data 3.36
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 3.35
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 3.35
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 3.35
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 3.3
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 3.28
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 3.28
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 3.27
Global epigenomic reconfiguration during mammalian brain development 3.26
Transcriptome of human white and brown adipose tissue biopsies 3.25
The gene expression profiles of gallbladder cancer 3.25
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 3.24
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 3.21
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 3.21
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 3.21
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 3.18
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 3.18
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 3.16
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 3.13
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 3.1
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 3.07
RNA-sequencing of human liver tissue 3.05
Gene expression profile of human placenta from T. Cruzi infected mothers 3.0
circRNA profile in hypopharyngeal cancer 2.9
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 2.89
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 2.88
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 2.83
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 2.82
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 2.82
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 2.82
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 2.75
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 2.74
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 2.74
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 2.73
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 2.73
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 2.71
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 2.71
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 2.67
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 2.66
TAF1 is critical for AE driven leukemogenesis 2.62
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 2.62
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 2.61
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 2.6
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 2.59
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 2.59
RNA-seq melanoma 2.57
Common inflammatory pathways between NEC and Crohn's disease 2.53
Epigenome regulation during epidermal lineage commitment [RNA-seq] 2.51
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 2.47
MRTF activates TEAD-YAP target gene expression 2.44
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 2.41
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 2.4
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 2.4
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 2.34
Gene expression profiling in metabolically heterogeneous human lung tumors 2.33
Dilated cardiomyopathy vs Myocarditis 2.27
Targeted enhancer activation by a subunit of the integrator complex 2.26
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 2.24
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 2.24
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 2.2
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 2.19
Fibroblasts in cholesteatoma activate osteoclasts. 2.12
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 2.08
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 2.04
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 2.02
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 2.01
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 2.01
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 1.98
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 1.97
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 1.97
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 1.97
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 1.97
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 1.96
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 1.94
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 1.94
Trans-differentiation of human adult peripheral blood T cells into neurons 1.94
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 1.91
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.89
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 1.89
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 1.87
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 1.84
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 1.82
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 1.82
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.8
Expression patterns in chronic thromboembolic pulmonary hypertension 1.8
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 1.79
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 1.78
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 1.75
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 1.75
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 1.73
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 1.72
Specific molecular signatures underlie response to decitabine in CMML 1.72
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 1.72
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 1.7
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 1.65
RNA expression profiles comparing primary and omental ovarian carcinoma samples 1.65
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 1.65
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 1.65
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 1.63
Gene expression of collecting duct carcinoma of the kidney 1.62
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 1.61
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 1.61
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 1.6
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.59
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.54
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 1.52
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 1.51
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 1.5
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 1.45
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 1.42
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 1.38
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 1.38
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.37
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 1.35
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 1.28
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.26
Measure transcript integrity using RNA-seq data 1.24
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 1.2
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 1.2
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 1.2
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.18
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 1.16
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 1.16
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 1.16
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 1.15
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 1.08
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 1.07
Differences in miRNA Detection Levels are Technology and Sequence Dependent 1.07
Transcriptome analysis of peripheral blood monocytes 1.05
Persistence of stem cell metabolism in cancers as a failure of differentiation 1.04
Hepatosplenic T cell lymphoma 1.04
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 1.04
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 1.01
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 0.96
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 0.96
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 0.94
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 0.94
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.91
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 0.91
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 0.9
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 0.9
Human ovarian granulosa cell transcriptome 0.88
Leucegene: AML sequencing (part 6) 0.87
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 0.86
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.86
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 0.83
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.82
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.81
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.81
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 0.79
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 0.79
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.76
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.76
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 0.76
Hepatic transcriptome of pediatric hepatoblastoma. 0.75
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 0.73
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.72
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.71
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 0.67
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.63
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.63
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.63
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 0.63
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 0.63
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.61
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.58
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.57
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.55
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.53
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.51
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 0.5
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.49
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.46
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.46
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.45
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.45
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.45
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.4
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.4
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.36
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 0.35
Transcriptomes in healthy and CHB fetal hearts 0.34
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.32
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.32
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 0.31
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 0.27
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 0.27
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.27
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.24
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.23
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.23
Evaluating pre-clinical models for studying NASH driven HCC. 0.21
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.14
Multiple sclerosis and EAE 0.13
Human optic chiasm from healthy controls and multiple sclerosis patients 0.13
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 0.11
A practical evaluation of alignment algorithms for RNA variant calling analysis 0.08
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.07
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.05
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.05
Molecular analysis of renal cell carcinoma with unclassfied histology 0.04
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.04
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.04
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation